Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Australia

API Announces Profit Shortfall

August 2006 | Company Finance Alert

Australian drugmaker Australian Pharmaceutical Industries (API) has announced a 41% fall in annual net profit after reportedly suffering from accounting problems. For the 12 months to April 2006, net profit stood at AUD20.4mn (US$15.51mn). This compares to a figure of AUD34.8mn (US$26.46mn) for the previous

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Macular Degeneration On The Rise

Companies / Australia Australia's ageing population is causing a substantial rise in cases of macular degeneration (MD) with the government expected to foot most of the bill. MD occurs when the macular - which is the part...
October 2006
'Trans-Tasman' Regulator Takes Shape

Companies / Australia Australia and New Zealand are planning to establish a joint regulatory agency. The new body will replace New Zealand's Medsafe and Australia's Therapeutic Goods Agency (TGA), and will be tasked with...
September 2006
Drug Firms Manipulating Clinical Data In Australia?

Companies / Australia One of Australia's leading cancer specialists has accused drug firms in the country of manipulating clinical trials in order to gain a commercial advantage. Professor Stephen Clarke of Sydney University,...
August 2006
Australia To Reimburse Herceptin?

Companies / Australia Elsewhere, a court in Melbourne, Australia has ended a seven-year class-action lawsuit into alleged price fixing in the animal vitamins industry. Roche, BASF and Aventis have now received increased fines...
July 2006
Australia's CSL To Acquire Zenyth

Companies / Australia Meanwhile, listed Australian biotechs Alchemia and Meditech are to merge, in a transaction which Alchemia claims will create one of the country's strongest biotechs. Alchemia specialises in anti-angiogenic...
July 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS